<DOC>
	<DOCNO>NCT01485666</DOCNO>
	<brief_summary>The purpose study evaluate feasibility Percutaneous Lead Management Kit HeartMate II driveline stabilization exit site management .</brief_summary>
	<brief_title>Thoratec 's Reduce Driveline Trauma Through Stabilization Exit Site Management Study</brief_title>
	<detailed_description>The Percutaneous Lead Management Kit combination commercially available component package together kit use HeartMate II driveline exit site cleaning , dress stabilization . The RESIST study prospective , non-randomized study evaluate wearability usability Percutaneous Lead Management Kit . Evaluation Percutaneous Lead Management Kit wearability usability perform 30 day enrollment . Study patient also follow 6 month evidence driveline infection .</detailed_description>
	<criteria>Signed informed consent form 16 year age older Supported HeartMate II LVAD continuously least 6 month currently hospitalize Will continue LVAD support least another 30 day No driveline systemic infection Willing able perform kit dress change least every 7 day 30 day Can fill study form Can use digital camera Willing return clinic final study visit 30 day High risk noncompliance Ongoing mechanical circulatory support HeartMate II LVAD Sensitivity kit component Skin condition may react kit component adhesive Already use component Percutaneous Lead Management Kit</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Thoratec</keyword>
	<keyword>HeartMate II</keyword>
	<keyword>heart-assist device</keyword>
	<keyword>driveline percutaneous lead management</keyword>
	<keyword>HeartMate II Percutaneous Lead Management</keyword>
</DOC>